ZA90644B - Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids - Google Patents

Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids

Info

Publication number
ZA90644B
ZA90644B ZA90644A ZA90644A ZA90644B ZA 90644 B ZA90644 B ZA 90644B ZA 90644 A ZA90644 A ZA 90644A ZA 90644 A ZA90644 A ZA 90644A ZA 90644 B ZA90644 B ZA 90644B
Authority
ZA
South Africa
Prior art keywords
hydroxyacids
indazole
hydroxymethyl
ethers
benzyl
Prior art date
Application number
ZA90644A
Other languages
English (en)
Inventor
Leandro Baiocchi
Baiocchi Leandro
Bruno Silvestrini
Silvestrini Bruno
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of ZA90644B publication Critical patent/ZA90644B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA90644A 1989-02-07 1990-01-29 Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids ZA90644B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8947620A IT1230441B (it) 1989-02-07 1989-02-07 Eteri della serie dell'indazolo

Publications (1)

Publication Number Publication Date
ZA90644B true ZA90644B (en) 1991-01-30

Family

ID=11261479

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA90644A ZA90644B (en) 1989-02-07 1990-01-29 Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids

Country Status (36)

Country Link
US (2) US4999367A (de)
EP (1) EP0382276B1 (de)
JP (1) JP2870925B2 (de)
KR (1) KR0145525B1 (de)
CN (2) CN1046505C (de)
AR (1) AR247386A1 (de)
AT (1) ATE127115T1 (de)
AU (1) AU624895B2 (de)
BG (1) BG50273A3 (de)
CA (1) CA2009503C (de)
CZ (1) CZ280121B6 (de)
DD (2) DD291995A5 (de)
DE (2) DE382276T1 (de)
DK (1) DK0382276T3 (de)
EG (1) EG19170A (de)
ES (1) ES2020171T3 (de)
FI (1) FI102678B (de)
GE (1) GEP19971030B (de)
GR (2) GR910300073T1 (de)
HU (1) HU204793B (de)
IL (1) IL93132A (de)
IN (1) IN170957B (de)
IT (1) IT1230441B (de)
LT (1) LT3604B (de)
LV (1) LV10612B (de)
NZ (1) NZ232258A (de)
PE (1) PE25091A1 (de)
PH (1) PH26552A (de)
PL (2) PL163730B1 (de)
PT (1) PT93067B (de)
RO (1) RO106252B1 (de)
RU (3) RU2066318C1 (de)
SK (1) SK278441B6 (de)
UA (1) UA26852C2 (de)
YU (1) YU47943B (de)
ZA (1) ZA90644B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
US5943270A (en) * 1997-11-26 1999-08-24 Intel Corporation Two-transistor DRAM cell for logic process technology
US7514463B2 (en) * 2004-08-20 2009-04-07 University Of Kansas Lonidamine analogues and their use in male contraception and cancer treatment
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
AU2009221087B2 (en) 2008-03-07 2013-12-05 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40
LT2254869T (lt) * 2008-03-07 2017-08-10 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Nauji 1-benzil-3-hidroksimetilindazolo dariniai ir jų panaudojimas gydyme ligų, susijusių su cx3cr1 ir p40 raiška
WO2009109654A2 (en) 2008-03-07 2009-09-11 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Novel 1-benzyl-3-hydroxymethyilindazole derivatives and use thereof in the treatment of diseases based on the expression mcp-1 and cx3cr1
SI2462119T1 (sl) 2009-08-03 2014-10-30 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Postopek za pripravo 1-benzil-3-hidroksimetil-1H-indazola in njegovih derivatov ter potrebni magnezijevi intermediati
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
EP3338776A1 (de) 2012-05-01 2018-06-27 Translatum Medicus Inc. Verfahren zur behandlung und diagnose von erblindenden augenerkrankungen
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
WO2013171317A1 (en) 2012-05-18 2013-11-21 Sanofi Pyrazole derivatives and their use as lpar5 antagonists
JP2015521183A (ja) 2012-05-18 2015-07-27 サノフイ ピリジン誘導体および病理学的血栓形成に関連する状態の治療へのその使用
CN108047136B (zh) * 2017-12-20 2021-07-09 长春普华制药股份有限公司 一种苄达酸的精制方法
CA3144861A1 (en) * 2019-06-25 2020-12-30 Translatum Medicus, Inc. Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
CN113929627A (zh) * 2021-10-19 2022-01-14 吕梁学院 一种宾达利的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL28032A (en) * 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
US3470298A (en) * 1969-01-29 1969-09-30 Acraf Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids
IT1131779B (it) 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1189052B (it) 1981-11-27 1988-01-28 Acraf Trattamento della cataratta
IT1194564B (it) 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
IT1197805B (it) 1986-08-01 1988-12-06 Acraf Metodo per il tratamento di lenti a contatto

Also Published As

Publication number Publication date
FI102678B1 (fi) 1999-01-29
GEP19971030B (en) 1997-06-13
EG19170A (en) 1994-11-30
EP0382276A3 (en) 1990-12-12
DE382276T1 (de) 1991-11-28
CN1044810A (zh) 1990-08-22
FI102678B (fi) 1999-01-29
US4999367A (en) 1991-03-12
CA2009503A1 (en) 1990-08-07
HU204793B (en) 1992-02-28
LV10612A (lv) 1995-04-20
CZ56390A3 (en) 1995-06-14
HU900689D0 (en) 1990-04-28
AU4906690A (en) 1990-08-16
DK0382276T3 (da) 1996-01-15
FI900577A0 (fi) 1990-02-06
DD291995A5 (de) 1991-07-18
IT8947620A0 (it) 1989-02-07
UA26852C2 (uk) 1999-12-29
PL163720B1 (pl) 1994-04-29
GR910300073T1 (en) 1991-11-15
PT93067A (pt) 1990-08-31
LV10612B (en) 1995-08-20
DE69021902D1 (de) 1995-10-05
IL93132A (en) 1994-05-30
JP2870925B2 (ja) 1999-03-17
PL163730B1 (pl) 1994-04-29
US5112986A (en) 1992-05-12
RU2044729C1 (ru) 1995-09-27
RO106252B1 (ro) 1993-03-31
LTIP872A (en) 1995-03-27
PE25091A1 (es) 1991-08-17
IT1230441B (it) 1991-10-23
NZ232258A (en) 1991-06-25
CN1034016C (zh) 1997-02-12
EP0382276B1 (de) 1995-08-30
HUT53088A (en) 1990-09-28
ES2020171A4 (es) 1991-08-01
JPH02240065A (ja) 1990-09-25
CZ280121B6 (cs) 1995-11-15
SK56390A3 (en) 1997-05-07
GR3018165T3 (en) 1996-02-29
BG50273A3 (en) 1992-06-15
DE69021902T2 (de) 1996-05-23
AU624895B2 (en) 1992-06-25
YU47943B (sh) 1996-07-24
KR900012913A (ko) 1990-09-03
AR247386A1 (es) 1994-12-29
ES2020171T3 (es) 1995-12-01
PH26552A (en) 1992-08-19
RU2055071C1 (ru) 1996-02-27
IN170957B (de) 1992-06-20
CN1088201A (zh) 1994-06-22
SK278441B6 (en) 1997-05-07
ATE127115T1 (de) 1995-09-15
KR0145525B1 (ko) 1998-08-17
LT3604B (en) 1995-12-27
EP0382276A2 (de) 1990-08-16
CA2009503C (en) 2000-04-11
CN1046505C (zh) 1999-11-17
YU20690A (sh) 1992-07-20
PT93067B (pt) 1995-12-29
IL93132A0 (en) 1990-11-05
DD295363A5 (de) 1991-10-31
RU2066318C1 (ru) 1996-09-10

Similar Documents

Publication Publication Date Title
GB2208510B (en) Ethers
IL90312A (en) Preparation of perfluoropolyethers
GR910300073T1 (en) Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids
IL96306A0 (en) Preparation of deoxyfluoronucleosides
IL93345A0 (en) Heterocyclic ethers
JPS6422856A (en) (azolyl-vinyl)-phenolalkenyl ethers
HRP940878B1 (en) Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids
EP0430866A3 (en) Connection piece
IL95024A0 (en) Preparation of 2-diazo-3-trisubstituted silyloxy-3-butenoates
GB8918394D0 (en) Preparation of polyhemiacetals
GB8902409D0 (en) Aliphatic compounds
JPS6450869A (en) Hydroxyethylazolyloxime ethers
PH23542A (en) Substituted phenoxybe-(dihalodimethyl-cyclopropylmethyl) ethers
IL89362A0 (en) Preparation of tetrabromotetralin
GB8711388D0 (en) Ethers
GB8718444D0 (en) Ethers
GB8811975D0 (en) Ethers
ZA863194B (en) Substituted azolylmethyl ethers
HRP940508A2 (en) New ethers
PH23464A (en) Substituted benzylcycloropylmethyl ethers
ZA878623B (en) Substituted phenoxybenzyl-(dihalodimethylcyclopropylmethyl)ethers
IL84495A0 (en) Substituted phenylbenzyl-(dimethyl-cyclopropylmethyl)ethers
PH22761A (en) Novel 4-acylresorcinol ethers
ZA909799B (en) Bruting of gem-stones
ZA898265B (en) Deur-en/of vensterraamstelsel